Interleukin-8 confers androgen-independent growth and migration of LNCaP: differential effects of tyrosine kinases Src and FAK
- 9 February 2004
- journal article
- Published by Springer Nature in Oncogene
- Vol. 23 (12) , 2197-2205
- https://doi.org/10.1038/sj.onc.1207344
Abstract
Interleukin-8 (IL-8), a chemokine implicated in the metastasis and angiogenesis of a variety of cancers, has been reported to be overexpressed in prostate cancer. In this study, we ascribe a new role for IL-8 in prostate cancer progression using LNCaP cells. We demonstrate that IL-8 activates the androgen receptor and confers androgen-independent growth, while serving as a potent chemotactic factor. Our evaluation of the possible signal pathways involved in androgen-independence and cell migration shows that the tyrosine kinases Src and FAK (focal adhesion kinase) are involved in IL-8-induced signaling. Pharmacological and genetic inhibitors of Src and FAK interfere with IL-8-induced cell migration, while only the Src inhibitor was able to repress androgen-independent growth. This suggests that both growth and migration depend on the activity of Src, whereas cell migration also requires the activation of FAK. Our evidence that IL-8-induced androgen-independent growth is, at least in part, due to androgen receptor activation includes (1) an inhibitor of androgen receptor activity diminishes cell growth; (2) androgen receptor transactivation potential is augmented by IL-8 and (3) androgen receptor is recruited to the promoter of prostate specific antigen (PSA) upon IL-8 treatment, based on chromatin immunoprecipitation experiments. Taken together, our data suggest that in addition to its role in metastasis and angiogenesis, IL-8 may also serve as a facilitator for androgen-independent transition of prostate cancers. To our knowledge, this is the first report about the tyrosine kinase signals and androgen receptor activation induced by IL-8 in prostate cancer cells. The observation that IL-8 mediates its growth and chemotactic effects via Src and FAK suggests the potential use for tyrosine kinase inhibitors at early stage of prostate cancer development.Keywords
This publication has 40 references indexed in Scilit:
- Bombesin, Lysophosphatidic Acid, and Epidermal Growth Factor Rapidly Stimulate Focal Adhesion Kinase Phosphorylation at Ser-910Journal of Biological Chemistry, 2003
- IL-8-Induced Migratory Responses through CXCR1 and CXCR2: Association with Phosphorylation and Cellular Redistribution of Focal Adhesion KinaseBiochemistry, 2003
- Identification of Human Male Germ Cell-associated Kinase, a Kinase Transcriptionally Activated by Androgen in Prostate Cancer CellsJournal of Biological Chemistry, 2002
- Androgen Receptor PhosphorylationJournal of Biological Chemistry, 2002
- 17β-estradiol, Progesterone, and Dihydrotestosterone Suppress the Growth of Human Melanoma by Inhibiting Interleukin-8 ProductionJournal of Investigative Dermatology, 2001
- Alterations in the focal adhesion kinase/Src signal transduction pathway correlate with increased migratory capacity of prostate carcinoma cellsOncogene, 2001
- Neutral endopeptidase inhibits prostate cancer cell migration by blocking focal adhesion kinase signalingJournal of Clinical Investigation, 2000
- CL1-GFP: AN ANDROGEN INDEPENDENT METASTATIC TUMOR MODEL FOR PROSTATE CANCERJournal of Urology, 2000
- Focal adhesion kinase (pp125FAK) expression, activation and association with paxillin and p50CSK in human metastatic prostate carcinomaInternational Journal of Cancer, 1996
- Interleukin-8 and MCAF: Novel Leukocyte Recruitment and Activating Cytokines (Part 1 of 2)Published by S. Karger AG ,1992